MoneyWorks4Me

Sanofi India - Quaterly Results

26 Oct 2021 Evaluate
The company witnessed a 9.89% growth in the revenue at Rs. 7545.00 millions for the quarter ended September 2021 as compared to Rs. 6866.00 millions during the year-ago period.The Net Profit of the company vaulted to 298.65% to Rs. 5298.00  millions from Rs. 1329.00 millions in the previous quarter.OP of the company witnessed a marginal growth to 2135.00 millions from 2071.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202012 201912 % Var
Sales 7545.00 6866.00 9.89 22687.00 21816.00 3.99 29019.00 30706.00 -5.49
Other Income 147.00 149.00 -1.34 581.00 736.00 -21.06 898.00 941.00 -4.57
PBIDT 2135.00 2071.00 3.09 6934.00 6197.00 11.89 8029.00 7594.00 5.73
Interest 5.00 4.00 25.00 14.00 14.00 0.00 18.00 3.00 500.00
PBDT 7022.00 2065.00 240.05 11812.00 5688.00 107.67 7594.00 6998.00 8.52
Depreciation 143.00 206.00 -30.58 558.00 618.00 -9.71 822.00 999.00 -17.72
PBT 6879.00 1859.00 270.04 11254.00 5070.00 121.97 6772.00 5999.00 12.89
TAX 1581.00 530.00 198.30 2714.00 1524.00 78.08 1996.00 1857.00 7.49
Deferred Tax -133.00 -6.00 2116.67 -216.00 -119.00 81.51 -114.00 -419.00 -72.79
PAT 5298.00 1329.00 298.65 8540.00 3546.00 140.83 4776.00 4142.00 15.31
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 28.30 30.16 -6.19 30.56 28.41 7.60 27.67 24.73 11.87
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..